The White House’s new “Great Healthcare Plan” fact sheet is out. After months of stalled congressional negotiations, the White House is now prioritizing a plan aimed at lowering prescription drug prices, increasing the number of pharmaceutical drugs that are available over the counter, promoting health-care price transparency, and increasing direct health-care funding to consumers via health savings accounts, among other measures.
Unsurprisingly, the fact sheet makes no mention of the Hyde amendment, which prohibits federal taxpayers from funding abortion. In case you missed it, I published a piece in National Review yesterday about how the administration has spent recent days sending mixed signals to pro-life groups on whether the White House is prioritizing Hyde protections in this year’s congressional health-care negotiations. As one administration official characterized the dynamic to NR, the administration is trying to navigate this year’s legislative landscape while also appealing to “people who aren’t necessarily just single-issue voters on abortion. . . . We’re not abandoning the pro-life movement, but we’re trying to operate with the constraints that we have to operate within.”